biovu

Biomarker for diabetic eye disease

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

VU, Celgene announce research partnership

Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market.

Roden named to NIH’s genomics advisory council

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH).

E-records shed light on drug response

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response.

A pain in the … genes

Vanderbilt researchers have discovered that variation in the gene encoding the potassium channel GIRK1 plays a role in modulating human pain perception.

Symposium highlights VU’s clinical, translational research

Nearly $5 million in internal pilot grants to jumpstart research projects. A tripling in the number of clinical and translational research publications. Novel research tools that have been snapped up by scientists around the world.

1 4 5 6 7